HLS Therapeutics 過去の業績
過去 基準チェック /06
HLS Therapeuticsの収益は年間平均-13%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間43.4% 2.4%割合で 増加しています。
主要情報
-13.0%
収益成長率
-11.7%
EPS成長率
| Pharmaceuticals 業界の成長 | 23.1% |
| 収益成長率 | 2.4% |
| 株主資本利益率 | -27.8% |
| ネット・マージン | -38.7% |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
Are Investors Undervaluing HLS Therapeutics Inc. (TSE:HLS) By 45%?
Oct 26
Pinning Down HLS Therapeutics Inc.'s (TSE:HLS) P/S Is Difficult Right Now
Sep 28Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results
May 12After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar
Apr 14Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt
Apr 06Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be
Nov 16Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt
Sep 13Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?
May 05HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Apr 05HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05
Mar 20HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05
Nov 30Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term
Nov 11We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt
Sep 14HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Aug 15HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Jul 14HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05
Jun 23HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
Jun 08HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
May 25HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
May 10Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook
Apr 30HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05
Apr 15HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05
Mar 26HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates
Mar 22収支内訳
収支内訳
HLS Therapeutics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 57 | -22 | 27 | 0 |
| 30 Jun 24 | 59 | -24 | 27 | 0 |
| 31 Mar 24 | 61 | -28 | 28 | 0 |
| 31 Dec 23 | 63 | -28 | 28 | 0 |
| 30 Sep 23 | 63 | -29 | 30 | 0 |
| 30 Jun 23 | 63 | -26 | 30 | 0 |
| 31 Mar 23 | 62 | -26 | 30 | 0 |
| 31 Dec 22 | 61 | -24 | 30 | 0 |
| 30 Sep 22 | 61 | -21 | 29 | 0 |
| 30 Jun 22 | 61 | -19 | 28 | 0 |
| 31 Mar 22 | 60 | -12 | 25 | 0 |
| 31 Dec 21 | 60 | -13 | 26 | 0 |
| 30 Sep 21 | 61 | -16 | 27 | 0 |
| 30 Jun 21 | 59 | -16 | 27 | 0 |
| 31 Mar 21 | 57 | -20 | 28 | 0 |
| 31 Dec 20 | 56 | -15 | 26 | 0 |
| 30 Sep 20 | 54 | -20 | 25 | 0 |
| 30 Jun 20 | 54 | -21 | 23 | 0 |
| 31 Mar 20 | 55 | -16 | 21 | 0 |
| 31 Dec 19 | 54 | -20 | 19 | 0 |
| 30 Sep 19 | 57 | -7 | 17 | 0 |
| 30 Jun 19 | 59 | -25 | 16 | 0 |
| 31 Mar 19 | 61 | -24 | 15 | 0 |
| 31 Dec 18 | 61 | -25 | 14 | 0 |
| 30 Sep 18 | 65 | -26 | 13 | 0 |
| 30 Jun 18 | 70 | -8 | 13 | 0 |
| 31 Mar 18 | 73 | -8 | 12 | 0 |
| 31 Dec 17 | 75 | -6 | 12 | 0 |
| 30 Sep 17 | 71 | -11 | 11 | 0 |
| 31 Dec 16 | 54 | -15 | 10 | 0 |
| 31 Dec 15 | 20 | -10 | 9 | 0 |
質の高い収益: HLSは現在利益が出ていません。
利益率の向上: HLSは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: HLSは利益が出ておらず、過去 5 年間で損失は年間13%の割合で増加しています。
成長の加速: HLSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: HLSは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( -51.1% ) と比較することは困難です。
株主資本利益率
高いROE: HLSは現在利益が出ていないため、自己資本利益率 ( -27.77% ) はマイナスです。